Average Scores of Perceived Usefulnessa by LHD Sizeb | |||||
---|---|---|---|---|---|
Potential Community Health Measure | All (n = 91, 30 LHDs) | Small (n = 22, 14 LHDs) | Medium (n = 23, 11 LHDs) | Large (n = 24, 4 LHDs) | Very Large (n = 22, 1 LHD) |
1. Vaccination Coverage School-age Children | 2.17 | 2.50 | 2.30 | 1.81 | 2.05 |
2. Flu Vaccination Coverage | 2.07 | 2.45 | 2.17 | 1.55 | 2.10 |
3. Prevalence Substance Abuse | 2.06 | 2.27 | 2.00 | 1.82 | 2.14 |
4. Hepatitis B and/or Hepatitis C | 2.05 | 2.32 | 2.26 | 1.82 | 1.76 |
5. Diabetes Prevalence | 2.03 | 2.23 | 2.13 | 1.81 | 1.95 |
6. HPV Vaccination Coverage | 1.99 | 2.18 | 2.17 | 1.48 | 2.09 |
7. Chlamydia/Gonorrhea/Syphilis Incidence | 1.92 | 2.10 | 1.96 | 1.64 | 2.00 |
8. Hypertension and Other Common Cardiovascular Disease Prevalence | 1.92 | 2.24 | 1.91 | 1.62 | 1.91 |
9. Asthma and COPD Prevalence | 1.91 | 2.18 | 1.78 | 1.50 | 2.18 |
10. Depression Prevalence | 1.85 | 1.90 | 1.55 | 1.87 | 2.09 |
11. HIV Screening | 1.83 | 1.95 | 1.86 | 1.52 | 1.95 |
12. Various Cancers Incidence | 1.82 | 2.14 | 1.64 | 1.68 | 1.82 |
13. Evidence of Violence or Trauma | 1.75 | 1.82 | 1.68 | 1.57 | 1.91 |
14. Chlamydia Screening | 1.69 | 1.76 | 1.78 | 1.48 | 1.73 |
15. Cholesterol Screening Patients with Cardiovascular Conditions | 1.69 | 2.00 | 1.83 | 1.43 | 1.48 |
16. Breast Cancer Screening | 1.67 | 2.05 | 1.55 | 1.45 | 1.64 |
17. Hemoglobin A1c (HbA1c) Testing, Diabetic Patients | 1.53 | 1.64 | 1.70 | 1.33 | 1.43 |
18. ER Use by Asthmatics | 1.49 | 1.55 | 1.24 | 1.18 | 2.00 |
19. Cholesterol Levels (LDL-C) < 100 mg/dL Cardiovascular Patients | 1.46 | 1.90 | 1.43 | 1.24 | 1.25 |
20. Hemoglobin A1c (HbA1c) Controlled < 8 Percent, Diabetic Patients | 1.29 | 1.57 | 1.23 | 1.14 | 1.24 |
21. Dental Caries Prevalence | 1.22 | 1.41 | .91 | 1.20 | 1.38 |
22. Asthma ADHD Prevalence Comorbidity Impact on ED Visits | 1.15 | 1.36 | .91 | .90 | 1.41 |
23. ER Use by People with Dental Pain or Infections | 1.12 | 1.23 | .86 | 1.00 | 1.36 |